Weight loss medications and bariatric surgery used to be considered last-resort options, but now, they’re everywhere. More ...

You may have heard of "Ozempic face" and "Ozempic butt." Well, now there's "Ozempic mouth" and "Ozempic feet" to describe ...

Pop quiz: would you prefer to take a medication as a pill or inject yourself with it? Somehow, I suspect that the vast ...

The use of GLP-1s among patients with type 2 diabetes appeared associated with significantly reduced risk for certain ...

On Friday, the company’s health services unit Evernorth unveiled new programs in a reliable growth area: helping payers ...

Nationally representative survey data reveals that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) use for obesity treatment more than tripled among US adults without diabetes between 2018 and ...

The FDA accepted Novo Nordisk's NDA for an oral formulation of Wegovy. The agency is expected to release its verdict on the ...

With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from ...

The rise in GLP-1 use among young women raises concerns about contraceptive efficacy and potential pregnancy risks. Learn ...

How can policy makers and health care leaders ensure affordable, equitable access to GLP-1 medications while managing their ...

Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent ...

Despite the $1,000-per-dose price tag, GLP-1s may offer long-term ROI by lowering chronic disease rates GLP-1 weight loss ...